Alphabet And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Alphabet (GOOG), MiMedx Group (MDXG), Edwards Lifesciences (EW) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Alphabet (GOOG)

10.9% sales growth and 27.36% return on equity

Alphabet Inc. provides various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment offers products and services, including ads, Android, Chrome, hardware, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube. It is also involved in the sale of apps and in-app purchases and digital content in the Google Play store; and Fitbit wearable devices, Google Nest home products, Pixel phones, and other devices, as well as in the provision of YouTube non-advertising services. The Google Cloud segment offers infrastructure, platform, and other services; Google Workspace that include cloud-based collaboration tools for enterprises, such as Gmail, Docs, Drive, Calendar, and Meet; and other services for enterprise customers. The Other Bets segment sells health technology and internet services. The company was founded in 1998 and is headquartered in Mountain View, California.

Earnings Per Share

As for profitability, Alphabet has a trailing twelve months EPS of $5.81.

PE Ratio

Alphabet has a trailing twelve months price to earnings ratio of 23.03. Meaning, the purchaser of the share is investing $23.03 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.36%.

Previous days news about Alphabet(GOOG)

  • According to Zacks on Wednesday, 6 March, "For example, Wall Street and the biggest AI winners thus far are already proven companies with massive cash hoards and well-established businesses like Microsoft ((MSFT Quick QuoteMSFT – Free Report) ) and Alphabet ((GOOGL Quick QuoteGOOGL – Free Report) ). "
  • According to Zacks on Wednesday, 6 March, "Given the booming scenario in APAC, not only Amazon but also its peers like Microsoft (MSFT Quick QuoteMSFT – Free Report) , Alphabet (GOOGL Quick QuoteGOOGL – Free Report) and Alibaba (BABA Quick QuoteBABA – Free Report) are leaving no stone unturned to expand their presence in the region."
  • Alphabet (googl) stock moves -0.51%: what you should know. According to Zacks on Tuesday, 5 March, "Analysts and investors alike will be keeping a close eye on the performance of Alphabet in its upcoming earnings disclosure. ", "In terms of valuation, Alphabet is presently being traded at a Forward P/E ratio of 19.68. "
  • According to Zacks on Thursday, 7 March, "The ‘Magnificent 7’ stocks - Apple (AAPL Quick QuoteAAPL – Free Report) , Amazon (AMZN Quick QuoteAMZN – Free Report) , Alphabet (GOOGL Quick QuoteGOOGL – Free Report) , Microsoft (MSFT Quick QuoteMSFT – Free Report) , Meta (META Quick QuoteMETA – Free Report) , Nvidia (NVDA Quick QuoteNVDA – Free Report) & Tesla (TSLA Quick QuoteTSLA – Free Report) - were again significant contributors to growth in 2023 Q4. "

2. MiMedx Group (MDXG)

9.8% sales growth and 62.09% return on equity

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and burns; AmnioFix, a semi-permeable protective barrier membrane product for the treatment of wounds related to surgical procedures; EpiCord and AmnioCord that are dehydrated human umbilical cord allografts intended for homologous applications; and AmnioFill that consists of particles of connective tissue matrix derived from placental disc and placental membranes. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.

Earnings Per Share

As for profitability, MiMedx Group has a trailing twelve months EPS of $0.43.

PE Ratio

MiMedx Group has a trailing twelve months price to earnings ratio of 18.77. Meaning, the purchaser of the share is investing $18.77 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 62.09%.

Volume

Today’s last reported volume for MiMedx Group is 648684 which is 9.62% below its average volume of 717791.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.7%, now sitting on 321.48M for the twelve trailing months.

Moving Average

MiMedx Group’s worth is under its 50-day moving average of $8.17 and way higher than its 200-day moving average of $7.32.

3. Edwards Lifesciences (EW)

9.4% sales growth and 22.34% return on equity

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Earnings Per Share

As for profitability, Edwards Lifesciences has a trailing twelve months EPS of $2.3.

PE Ratio

Edwards Lifesciences has a trailing twelve months price to earnings ratio of 40.35. Meaning, the purchaser of the share is investing $40.35 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.34%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Edwards Lifesciences’s EBITDA is 8.38.

Moving Average

Edwards Lifesciences’s worth is way higher than its 50-day moving average of $79.52 and way higher than its 200-day moving average of $78.08.

Yearly Top and Bottom Value

Edwards Lifesciences’s stock is valued at $92.82 at 15:22 EST, under its 52-week high of $94.87 and way above its 52-week low of $60.57.

4. Waste Connections (WCN)

9% sales growth and 10.3% return on equity

Waste Connections, Inc. provides non-hazardous waste collection, transfer, disposal, and resource recovery services in the United States and Canada. It offers collection services to residential, commercial, municipal, industrial, and exploration and production (E&P) customers; landfill disposal services; and recycling services for various recyclable materials, including compost, cardboard, mixed paper, plastic containers, glass bottles, and ferrous and aluminum metals. The company owns and operates transfer stations that receive compact and/or load waste to be transported to landfills or treatment facilities through truck, rail, or barge; and intermodal services for the rail haul movement of cargo and solid waste containers in the Pacific Northwest through a network of intermodal facilities. In addition, it provides E&P waste treatment, recovery, and disposal services for waste resulting from oil and natural gas exploration and production activity, such as drilling fluids, drill cuttings, completion fluids, and flowback water; production wastes and produced water during a well's operating life; contaminated soils that require treatment during site reclamation; and substances, which require clean-up after a spill, reserve pit clean-up, or pipeline rupture. Further, the company offers leasing services to its customers. Waste Connections, Inc. was founded in 1997 and is based in Woodbridge, Canada.

Earnings Per Share

As for profitability, Waste Connections has a trailing twelve months EPS of $2.94.

PE Ratio

Waste Connections has a trailing twelve months price to earnings ratio of 56.82. Meaning, the purchaser of the share is investing $56.82 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.3%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 21.3% and 16.9%, respectively.

Volume

Today’s last reported volume for Waste Connections is 424178 which is 58.77% below its average volume of 1028940.

Moving Average

Waste Connections’s value is above its 50-day moving average of $155.25 and way higher than its 200-day moving average of $142.29.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Waste Connections’s EBITDA is 6.18.

5. Humana (HUM)

8.7% sales growth and 15.68% return on equity

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Earnings Per Share

As for profitability, Humana has a trailing twelve months EPS of $20.

PE Ratio

Humana has a trailing twelve months price to earnings ratio of 17.17. Meaning, the purchaser of the share is investing $17.17 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.68%.

Volume

Today’s last reported volume for Humana is 690764 which is 66.72% below its average volume of 2075700.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 34.1% and a negative 33.8%, respectively.

Sales Growth

Humana’s sales growth is 10.5% for the ongoing quarter and 8.7% for the next.

Previous days news about Humana(HUM)

  • Humana (hum) inks value-based deal to offer better kidney care. According to Zacks on Wednesday, 6 March, "The recent collaboration may be looked at as further solidifying ties between Humana and Strive, who initially joined forces back in 2020 to provide enhanced kidney care to Humana’s Medicare Advantage and Commercial members in Indiana and Kentucky. ", "In the past, Humana has entered into partnerships with several kidney care providers to better serve its customer base. "
  • Humana (hum) increases yet falls behind market: what investors need to know. According to Zacks on Wednesday, 6 March, "In the latest trading session, Humana (HUM Quick QuoteHUM – Free Report) closed at $339.08, marking a +0.34% move from the previous day. ", "The investment community will be closely monitoring the performance of Humana in its forthcoming earnings report. "

6. Restaurant Brands International (QSR)

7.7% sales growth and 38.19% return on equity

Restaurant Brands International Inc. operates as a quick-service restaurant company in Canada, the United States, and internationally. It operates through four segments: Tim Hortons (TH), Burger King (BK), Popeyes Louisiana Kitchen (PLK), and Firehouse Subs (FHS). The company owns and franchises TH chain of donut/coffee/tea restaurants that offer blend coffee, tea, and espresso-based hot and cold specialty drinks; and fresh baked goods, including donuts, Timbits, bagels, muffins, cookies and pastries, grilled paninis, classic sandwiches, wraps, soups, and other food products. It is also involved in owning and franchising BK, a fast-food hamburger restaurant chain, which offers flame-grilled hamburgers, chicken and other specialty sandwiches, French fries, soft drinks, and other food items; and PLK quick service restaurants that provide Louisiana-style fried chicken, chicken tenders, fried shrimp and other seafood, red beans and rice, and other regional items. In addition, the company owns and franchises FHS quick service restaurants that offer meats and cheese, chopped salads, chili and soups, signature and other sides, soft drinks, and local specialties. Restaurant Brands International Inc. was founded in 1954 and is headquartered in Toronto, Canada.

Earnings Per Share

As for profitability, Restaurant Brands International has a trailing twelve months EPS of $3.76.

PE Ratio

Restaurant Brands International has a trailing twelve months price to earnings ratio of 21.19. Meaning, the purchaser of the share is investing $21.19 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.19%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Restaurant Brands International’s EBITDA is 5.37.

Sales Growth

Restaurant Brands International’s sales growth is 7.1% for the current quarter and 7.7% for the next.

7. Lakeland Industries (LAKE)

5.7% sales growth and 5.43% return on equity

Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company also provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of approximately 1,600 safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. The company was incorporated in 1982 and is headquartered in Huntsville, Alabama.

Earnings Per Share

As for profitability, Lakeland Industries has a trailing twelve months EPS of $0.87.

PE Ratio

Lakeland Industries has a trailing twelve months price to earnings ratio of 18.91. Meaning, the purchaser of the share is investing $18.91 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.43%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Lakeland Industries’s EBITDA is 22.63.

8. Pinnacle Financial Partners (PNFP)

5.6% sales growth and 9.73% return on equity

Pinnacle Financial Partners, Inc., together with its subsidiaries, operates as the bank holding company for Pinnacle Bank that provides various banking products and services in the United States. The company accepts various deposits, including savings, checking, noninterest-bearing and interest-bearing checking, money market, and certificate of deposit accounts. Its loan products include commercial loans, such as equipment and working capital loans; commercial real estate loans comprising investment properties and business loans secured by real estate; and loans to individuals consisting of secured and unsecured installment and term loans, lines of credit, residential first mortgage loans, and home equity loans and lines of credit, as well as provides credit cards for consumers and businesses. The company also offers various securities and other financial products; investment products; brokerage and investment advisory programs; and fiduciary and investment management services, such as personal trust, endowments, foundations, individual retirement accounts, pensions, and custody. In addition, it provides insurance agency services primarily in the property and casualty area; merger and acquisition advisory services; and private debt, equity and mezzanine, and other middle-market advisory services. Further, the company offers treasury management, telephone and online banking, mobile banking, debit cards, direct deposit and remote deposit capture, mobile deposit option, automated teller machine, and cash management services. It serves individuals, small to medium-sized businesses, and professional entities. As of December 31, 2020, the company operated 114 offices, including 48 in Tennessee, 36 in North Carolina, 20 in South Carolina, 9 in Virginia, and 1 in Georgia. Pinnacle Financial Partners, Inc. was incorporated in 2000 and is headquartered in Nashville, Tennessee.

Earnings Per Share

As for profitability, Pinnacle Financial Partners has a trailing twelve months EPS of $7.14.

PE Ratio

Pinnacle Financial Partners has a trailing twelve months price to earnings ratio of 11.87. Meaning, the purchaser of the share is investing $11.87 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.73%.

Sales Growth

Pinnacle Financial Partners’s sales growth for the next quarter is 5.6%.

Leave a Reply

Your email address will not be published. Required fields are marked *